Education and Training
Residency - Pediatrics, Johns Hopkins Hospital, Baltimore, MD
Fellowship - Pediatric Hematology/Oncology, Children’s Hospital of Philadelphia, Philadelphia, PA
Fellowship - Pediatric Neuro-Oncology, Children’s Hospital of Philadelphia, Philadelphia, PA
MSCE - Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA
Titles and Academic Titles
Instructor and Attending Physician
Departments and Services
Neurofibromatosis-associated tumors of childhood
Kotch C, Avery R, Getz KD, et al. Risk Factors for Treatment Refractory and Relapsed Optic Pathway Glioma in Children with Neurofibromatosis Type 1 [published online ahead of print, 2022 Jan 9]. Neuro Oncol. 2022;noac013. doi:10.1093/neuonc/noac013
Kotch C, Friedman DF, Wilkins BJ, et al. “Conservative Management of Alloimmune Hemolysis and Cholestasis With Extreme Laboratory Abnormalities”. Pediatrics, 2021;147(2):e20193367
Zhao X, Kotch C, Fox E, et al. “NTRK Fusions Identified in 1,217 Pediatric Tumors: the Frequency, Fusion Partners, and Clinical Outcome”. JCO Precision Oncology, 2021:5 204-214
Fundora J, Kotch C, Serwint J. “A 7-month-old with fever and facial palsy”. Pediatrics In Review. Pediatrics in Review, October 2020, 41 (Supplement 1) S30-S32
Matesanz S, Kotch C, Perrone C, et al. “Expanding the MOG phenotype: Brainstem Encephalitis with Punctate and Curvilinear Enhancement”, Neurology: Neuroimmunology & Neuroinflammation, 2019 Nov, 6 (6) e619
Kotch C, Barrett D & Teachey DT. “Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome”, Expert Review of Clinical Immunology, 2019 Jun 20:1-10.
Kotch C, Avery RA, et al. “Predictors of Early Treatment-Refractory and Relapsed Optic Pathway Glioma”. Children’s Tumor Foundation NF Virtual Conference, June 2021. (Platform presentation)
Kotch C, Fisher MJ, Zhong Y, Gallo D, Fan E, Lin F, Chen J, Santi M, & Li MM. “Atypical Teratoid Rhabdoid Tumor in a Child With Neurofibromatosis Type 2: A Novel Dual Diagnosis” [Abstract]. In: Proceedings of the 2021 Annual Clinical Genetics Meeting, Virtual: ACMG; 2021, Abstract nr eP058 (Poster presentation)
Kotch, C & Hogarty, M (2021). Langerhans Cell Histiocytosis and Diabetes Insipidus. In C Alter (Ed.), Diabetes Insipidus: A Pocket Guide, Springer Nature. Accepted, In production
Mcglynn, J & Kotch, C (2021). Hemostasis & Thrombosis. In R. Tenney-Soeiro (Ed.), Netter’s Pediatrics, 2nd Edition, Philadelphia: Elsevier. Accepted, In production
Kotch, CS & Yusuf, Z. (2015). Oncology. In H. Hughes & L. Kahl (Ed.), The Harriet Lane Handbook, 21st Edition (pp. 523-542). Philadelphia: Elsevier.
Awards and Honors
2021, Neurofibromatosis Young Investigators Forum Travel Award
2021. Academic Enrichment Fund Award
Leadership and Memberships
2020-present, American Society of Pediatric Hematology/Oncology
2019-present, Society for Neuro-Oncology
2017-present, Children’s Oncology Group
Patient Experience Ratings
About the Patient Experience Rating System
The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient's protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments.
Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care.
The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.